Mitsubishi Tanabe Pharma Corporation announced that Shigehiko Hattori resigned as an Outside Board Director of the Company at the conclusion of the 12th Ordinary General Meeting of Shareholders held on June 21, 2019. Kazutoshi Murao, an Outside Director, was appointed as a committee member of the Nomination Committee by the Board of Directors.